CNSA News : 2018 : April

Faculty Feature | Dr. David Loewenstein

Dr. David Loewenstein | Director, Center for Cognitive Neuroscience & Aging and Professor, Psychiatry & Behavioral Sciences

You have a long history with UM. Tell us about your ties to the university. I have considerable ties and affection for the University. I was born at Jackson Memorial Hospital, my parents worked and taught at UM. As a kid I went to some of the UM football games and this is my 32nd year as a faculty member.

Read more »

Novel Strategy Shows Promise for Earlier Detection of Alzheimer’s Disease

Finding an effective way to identify people with mild cognitive impairment who are most likely to go on to develop Alzheimer’s disease has eluded researchers for years. But now, a team of researchers led by David Loewenstein, Ph.D., director of the Center for Cognitive Neuroscience and Aging (CNSA) and professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, has devised a novel strategy that could do just that.

Read more »

Dr. Rosie Curiel Cid Receives Prestigious $3M NIH Grant for Research in Alzheimer’s Disease

Dr. Rosie Curiel Cid, Assistant Professor of Psychiatry, joined the Miller School faculty in 2011. As a geriatric neuropsychologist, her expertise lies with the assessment of neurodegenerative conditions particularly Alzheimer’s disease and related disorders. With Alzheimer’s disease being the sixth leading cause of death in the United States currently affecting 5.7 million people, the number is expected to reach 14 million by 2050. Dr. Curiel Cid has devoted her research to combating this terrible disease, and was recently awarded a prestigious $3 million grant by the NIH/NIA. Read on to learn more about her important work and how she obtained such a coveted award.

Read more »

There is help for Alzheimer's patients and their caregivers

It’s a heart-wrenching diagnosis that is affecting too many families around the world. Currently, more than five million Americans suffer from Alzheimer’s disease, and as our population ages, this number could potentially skyrocket to 16 million by 2050. It is the sixth leading cause of death in the U.S., causing tremendous financial disability and other burdens for caregivers.

Read more »